Functional abdominal pain syndrome

Functional abdominal pain syndrome is characterized by frequent or chronic stomach pain and a reduction in everyday activity. The pain is persistent, near-constant, or regularly reoccurring. The pain is not related to food intake or defecation. Typically, the level of abdominal pain in functional abdominal pain syndrome seldom varies, with maximum pain being felt the majority of the time. functional abdominal pain syndrome is frequently coupled with a proclivity to experience and report additional somatic symptoms of discomfort, such as chronic pain believed to be connected to the gynecological or urinary systems. == Causes ==

Functional abdominal pain syndrome is a functional gastrointestinal disorder. Functional gastrointestinal disorders (FGD) are common medical conditions characterized by recurrent and persistent gastrointestinal symptoms caused by improper functioning of the enteric system in the absence of any identifiable organic or structural pathology, such as ulcers, inflammation, tumors or masses. == Mechanism ==

The pain from functional abdominal pain syndrome is thought to be caused by changes in descending modulation, central sensitization of the spinal dorsal horn, peripheral enhancement of the visceral pain afferent signal, and, lastly, central amplification. For example, about one-third of individuals with IBS report that their symptoms started after an acute infection episode; this is a phenomenon known as postinfectious IBS (PI-IBS). PI-IBS has consistently been linked to the existence of a low-grade inflammatory infiltrate. According to theory, this inflammatory infiltration results in increased sensitivity and field of peripheral receptors, the latter of which causes hyperalgesia by recruiting and activating nociceptors that were previously silent. == Diagnosis ==

Since pain is the primary symptom of functional abdominal pain syndrome, obtaining a complete medical history and conducting a comprehensive physical examination continue to be essential components of the diagnosing process. The functional abdominal pain syndrome patient should be asked to provide a thorough history that thoroughly examines the timeline of pain occurrences, especially in connection with surgery, infection, or traumatic life events. The Rome IV diagnostic criteria for functional abdominal pain syndrome is as follows: • Constant or almost constant abdominal pain. • There is either no correlation or a very weak one between pain and physiological processes (e.g., eating, feces or menses). • Some aspects of daily functioning are limited by pain. • Pain is not feigned. • No other medical illness or structural or functional gastrointestinal issue may account for the pain. To fit the Rome IV diagnostic criteria for functional abdominal pain syndrome the patient must fit all of the above criteria and the criteria must be met over the past three months, with the onset of symptoms occurring at least six months before diagnosis. When diagnosing functional abdominal pain syndrome, a number of other functional GI illnesses should be taken into account initially. IBS may be taken into consideration if the pain is accompanied by changes in bowel motions (frequent, loose stools or harder, infrequent stools). Functional gall bladder disease or sphincter of Oddi dysfunction should be considered if the pain is significant, occurs at different intervals (not daily), and is located in the right upper quadrant or epigastrium. Consider functional dyspepsia if the discomfort is in the epigastrium and does not meet the criteria for functional gallbladder disease. == Treatment ==

There is no definite agreement on how to best manage functional abdominal pain syndrome in adults. As a result, the majority of currently employed therapies are founded on data and firsthand knowledge from other functional bowel diseases and chronic pain syndromes. It is helpful to categorize therapy modalities into three groups: psychological interventions, pharmaceutical therapies, and general measures. They may also be helpful in the treatment of functional abdominal pain syndrome due to their dual effects of direct pain management and antidepressant properties. Venlafaxine and duloxetine are two examples of more recent medications with combined serotonin and norepinephrine reuptake inhibitors (SNRIs), which have been shown to reduce pain in some somatic pain disorders and may be helpful in functional abdominal pain syndrome. Patients with co-occurring anxiety and depression may benefit from both SNRIs and selective serotonin-reuptake inhibitors (SSRIs). The majority of analgesics, such as aspirin and nonsteroidal anti-inflammatory medications, don't really help much, maybe because they mostly have peripheral effects. There hasn't been a study explicitly looking at adult functional abdominal pain syndrome and psychological therapy. Studies on non-gastrointestinal pain diseases and other painful functional gastrointestinal illnesses, however, point to the potential benefit of psychological therapies. dynamic or interpersonal psychotherapy, and cognitive behavioral therapy are among the interventions that may prove advantageous. The most effective way to manage impairment resulting from refractory chronic pain may be to refer patients to pain treatment clinics for multidisciplinary treatment programs. While the previously discussed psychological treatments have demonstrated improvements in mood, coping, quality of life, and health care costs, their effect on specific visceral or somatic symptoms is less clear, indicating that their most effective application may be in conjunction with symptomatic treatment. == Epidemiology ==

Due to a lack of data and methodological challenges in distinguishing functional abdominal pain syndrome from other more prevalent functional gastrointestinal diseases like IBS and functional dyspepsia, the epidemiology of the disease is not fully understood. Nonetheless, compared to functional dyspepsia or IBS, functional abdominal pain syndrome is generally thought to be a less frequent. The condition affects women more frequently than men (3:2), with a peak in prevalence occurring in the fourth decade of life. == Notes ==